Skip to content
The Policy VaultThe Policy Vault

Targretin (bexarotene 1% gel – Bausch Health, generic)Cigna

Adult T-Cell Leukemia/Lymphoma

Initial criteria

  • Patient has smoldering symptomatic subtype
  • Medication is used as first-line therapy
  • Medication is prescribed by or in consultation with an oncologist or a dermatologist

Approval duration

1 year